Filing Details

Accession Number:
0001237899-14-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-24 16:11:02
Reporting Period:
2014-02-20
Filing Date:
2014-02-24
Accepted Time:
2014-02-24 16:11:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226435 A Murray Goldberg 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Administration & Asst Secr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-20 30,000 $30.63 93,102 No 4 M Direct
Common Stock Disposition 2014-02-20 2,818 $326.05 90,284 No 4 F Direct
Common Stock Disposition 2014-02-20 14,017 $326.05 76,267 No 4 F Direct
Common Stock Acquisiton 2014-02-20 10,424 $79.53 86,691 No 4 M Direct
Common Stock Disposition 2014-02-20 2,542 $326.05 84,149 No 4 F Direct
Common Stock Disposition 2014-02-20 4,064 $326.05 80,085 No 4 F Direct
Common Stock Acquisiton 2014-02-20 4,168 $72.60 84,253 No 4 M Direct
Common Stock Disposition 2014-02-20 927 $326.05 83,326 No 4 F Direct
Common Stock Disposition 2014-02-20 1,670 $326.05 81,656 No 4 F Direct
Common Stock Acquisiton 2014-02-20 2,976 $65.76 84,632 No 4 M Direct
Common Stock Disposition 2014-02-20 600 $326.05 84,032 No 4 F Direct
Common Stock Disposition 2014-02-20 1,225 $326.05 82,807 No 4 F Direct
Common Stock Acquisiton 2014-02-20 3,084 $56.61 85,891 No 4 M Direct
Common Stock Disposition 2014-02-20 535 $326.05 85,356 No 4 F Direct
Common Stock Disposition 2014-02-20 996 $326.05 84,360 No 4 F Direct
Common Stock Disposition 2014-02-21 400 $327.84 83,960 No 4 S Direct
Common Stock Disposition 2014-02-21 500 $328.50 83,460 No 4 S Direct
Common Stock Disposition 2014-02-21 400 $332.67 83,060 No 4 S Direct
Common Stock Disposition 2014-02-21 300 $333.90 82,760 No 4 S Direct
Common Stock Disposition 2014-02-21 2,824 $334.45 79,936 No 4 S Direct
Common Stock Disposition 2014-02-21 3,143 $335.67 76,793 No 4 S Direct
Common Stock Disposition 2014-02-21 4,158 $336.42 72,635 No 4 S Direct
Common Stock Disposition 2014-02-21 2,126 $337.51 70,509 No 4 S Direct
Common Stock Disposition 2014-02-21 5,204 $338.51 65,305 No 4 S Direct
Common Stock Disposition 2014-02-21 2,203 $339.31 63,102 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-20 30,000 $0.00 30,000 $30.63
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-20 3,084 $0.00 3,084 $56.61
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-20 2,976 $0.00 2,976 $65.76
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-20 4,168 $0.00 4,168 $72.60
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-20 10,424 $0.00 10,424 $79.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
66,736 2020-12-14 No 4 M Direct
0 2011-08-15 2015-12-19 No 4 M Direct
0 2011-09-06 2015-12-19 No 4 M Direct
0 2011-09-08 2015-12-19 No 4 M Direct
0 2012-01-19 2016-12-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,650 Indirect By 401(k) Plan
Common Stock 750 Indirect by Spouse
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 400 shares of Company stock on February 21, 2014 at prices ranging from $327.77 to $327.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  3. Represents volume-weighted average price of sales of 500 shares of Company stock on February 21, 2014 at prices ranging from $328.01 to $328.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  4. Represents volume-weighted average price of sales of 400 shares of Company stock on February 21, 2014 at prices ranging from $332.44 to $332.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  5. Represents volume-weighted average price of sales of 2,824 shares of Company stock on February 21, 2014 at prices ranging from $334.00 to $334.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  6. Represents volume-weighted average price of sales of 3,143 shares of Company stock on February 21, 2014 at prices ranging from $335.01 to $335.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  7. Represents volume-weighted average price of sales of 4,158 shares of Company stock on February 21, 2014 at prices ranging from $336.01 to $336.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  8. Represents volume-weighted average price of sales of 2,126 shares of Company stock on February 21, 2014 at prices ranging from $337.00 to $337.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  9. Represents volume-weighted average price of sales of 5,204 shares of Company stock on February 21, 2014 at prices ranging from $338.09 to $338.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  10. Represents volume-weighted average price of sales of 2,203 shares of Company stock on February 21, 2014 at prices ranging from $339.10 to $339.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 21, 2014 at each separate price.
  11. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.